Breakthrough in Accelerated TMS for Treatment-Resistant Bipolar Depression
Transcranial magnetic stimulation (TMS), first approved by the FDA in 2008 for the treatment of major depressive disorder (MDD), has…
World Trending News
Transcranial magnetic stimulation (TMS), first approved by the FDA in 2008 for the treatment of major depressive disorder (MDD), has…
March 11, 2024 – Gold Coast, Queensland: Novo Nordisk, a leading pharmaceutical company, has unveiled exciting developments in the realm…